|
ZFP91 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8926499999905E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.344010E-02 |
| Normal-vs-Stage2 |
7.798400E-02 |
| Normal-vs-Stage3 |
4.07839999994053E-07 |
| Normal-vs-Stage4 |
6.64909999947838E-07 |
| Stage1-vs-Stage2 |
6.837000E-01 |
| Stage1-vs-Stage3 |
5.981900E-04 |
| Stage1-vs-Stage4 |
6.828900E-04 |
| Stage2-vs-Stage3 |
8.300200E-02 |
| Stage2-vs-Stage4 |
6.161800E-02 |
| Stage3-vs-Stage4 |
7.579800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.67619999999325E-05 |
| Normal-vs-AfricanAmerican |
2.42530000005292E-06 |
| Normal-vs-Asian |
9.856600E-01 |
| Caucasian-vs-AfricanAmerican |
4.044200E-02 |
| Caucasian-vs-Asian |
2.947200E-01 |
| AfricanAmerican-vs-Asian |
5.116200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.94380000004568E-06 |
| Normal-vs-Female |
1.823470E-03 |
| Male-vs-Female |
2.446600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.595890E-02 |
| Normal-vs-Age(41-60Yrs) |
2.581100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.16199999997424E-06 |
| Normal-vs-Age(81-100Yrs) |
3.074000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.006000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.878400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.996000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.175200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.304800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.059800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.283000E-01 |
| Normal-vs-Grade 2 |
2.576100E-02 |
| Normal-vs-Grade 3 |
1.82059999997985E-06 |
| Normal-vs-Grade 4 |
1.0121000004748E-07 |
| Grade 1-vs-Grade 2 |
3.681400E-01 |
| Grade 1-vs-Grade 3 |
5.393700E-02 |
| Grade 1-vs-Grade 4 |
7.222300E-03 |
| Grade 2-vs-Grade 3 |
6.318700E-03 |
| Grade 2-vs-Grade 4 |
1.829320E-04 |
| Grade 3-vs-Grade 4 |
6.248400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.727600E-01 |
| Normal-vs-ccB subtype |
4.56240000001884E-06 |
| ccA subtype-vs-ccB subtype |
1.017470E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.379400E-04 |
| Normal-vs-N1 |
1.409390E-01 |
| N0-vs-N1 |
5.741800E-01 |
|
|
